Novo Nordisk Investigational Site — Newark, New Jersey

Novo Nordisk Investigational Site is a clinical research site located in Newark, New Jersey, United States 07112.

Crixeo Health Trust Score: 67/100 (FAIR). This profile has not yet been claimed by the site owner.

Novo Nordisk Investigational Site has participated in 9 clinical trials.

Therapeutic areas: Congenital Bleeding Disorder, Haemophilia A With Inhibitors, Haemophilia B With Inhibitors.

Sponsors: Novo Nordisk A/S.

Sponsor Feasibility Report

Trust Score: 67/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Novo Nordisk Investigational Site?

Novo Nordisk Investigational Site has a Crixeo Trust Score of 67/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Novo Nordisk Investigational Site conducted?

Novo Nordisk Investigational Site has 9 clinical trials on record. Their work covers Congenital Bleeding Disorder, Haemophilia A With Inhibitors, Haemophilia B With Inhibitors.

Is Novo Nordisk Investigational Site accredited by Crixeo Health?

Novo Nordisk Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Novo Nordisk Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.